AU2001225466A1 - Pyrimidine derivatives having antitumor effect - Google Patents

Pyrimidine derivatives having antitumor effect

Info

Publication number
AU2001225466A1
AU2001225466A1 AU2001225466A AU2546601A AU2001225466A1 AU 2001225466 A1 AU2001225466 A1 AU 2001225466A1 AU 2001225466 A AU2001225466 A AU 2001225466A AU 2546601 A AU2546601 A AU 2546601A AU 2001225466 A1 AU2001225466 A1 AU 2001225466A1
Authority
AU
Australia
Prior art keywords
antitumor effect
pyrimidine derivatives
alkyl
hydrogen atom
independently hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001225466A
Other languages
English (en)
Inventor
Shinji Suzuki
Hideyuki Takenaka
Hidekazu Tanaka
Kazuo Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2001225466A1 publication Critical patent/AU2001225466A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001225466A 2000-01-14 2001-01-09 Pyrimidine derivatives having antitumor effect Abandoned AU2001225466A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000005553 2000-01-14
JP2000-5553 2000-01-14
PCT/JP2001/000036 WO2001051488A1 (fr) 2000-01-14 2001-01-09 Derives de la pyrimidine a effet anti-tumoral

Publications (1)

Publication Number Publication Date
AU2001225466A1 true AU2001225466A1 (en) 2001-07-24

Family

ID=18534207

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001225466A Abandoned AU2001225466A1 (en) 2000-01-14 2001-01-09 Pyrimidine derivatives having antitumor effect

Country Status (10)

Country Link
US (1) US6800630B2 (ko)
EP (1) EP1251129B1 (ko)
KR (1) KR20020079779A (ko)
CN (1) CN1416429A (ko)
AT (1) ATE268769T1 (ko)
AU (1) AU2001225466A1 (ko)
CA (1) CA2396324A1 (ko)
DE (1) DE60103732T2 (ko)
ES (1) ES2222331T3 (ko)
WO (1) WO2001051488A1 (ko)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE208772T1 (de) 1993-10-01 2001-11-15 Novartis Erfind Verwalt Gmbh Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5439918A (en) 1994-03-14 1995-08-08 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
TW548275B (en) * 1998-07-16 2003-08-21 Shionogi & Co A pyrimidine derivative having antiturnor activity

Also Published As

Publication number Publication date
US6800630B2 (en) 2004-10-05
ES2222331T3 (es) 2005-02-01
CA2396324A1 (en) 2001-07-19
EP1251129A4 (en) 2003-03-05
ATE268769T1 (de) 2004-06-15
DE60103732T2 (de) 2005-06-30
DE60103732D1 (de) 2004-07-15
US20030203894A1 (en) 2003-10-30
CN1416429A (zh) 2003-05-07
EP1251129A1 (en) 2002-10-23
WO2001051488A1 (fr) 2001-07-19
KR20020079779A (ko) 2002-10-19
EP1251129B1 (en) 2004-06-09

Similar Documents

Publication Publication Date Title
BE2018C008I2 (ko)
WO2000004014A1 (fr) Derives de pyrimidine manifestant une activite antitumorale
KR100188846B1 (en) Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
AU2267195A (en) Dc-89 derivative
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
HK1107814A1 (en) Thiadiazoline derivatives for treating cancer
AU9281198A (en) Benzofuran derivatives
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
AU2722095A (en) Novel pyrrolocarbazoles
AU648338B2 (en) Benzene, pyridine and pyrimidine derivatives
AU696948B2 (en) Piperidine derivatives
AU6731100A (en) Integrase inhibitors containing aromatic heterocycle derivatives
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
AU2001225466A1 (en) Pyrimidine derivatives having antitumor effect